Togni E, Travaglini P, Beretta C, Berardinelli L, Vegeto A, Mocchegiani E, Fabris N, Egidi F, Ponticelli C, Faglia G
Istituto di Scienze Endocrine, University of Milano, Italy.
J Endocrinol Invest. 1990 Oct;13(9):709-15. doi: 10.1007/BF03349606.
The interrelationships between PRL, thymulin and Zn, were studied in 25 patients with chronic renal failure (CRF) undergoing kidney transplantation and immunosuppressed with cyclosporine A (CsA). The possible role of serum PRL levels in predicting allograft rejection was also investigated. Before the kidney transplant serum PRL levels were significantly higher than in normals (mean +/- SE, 28.3 +/- 7.1 vs 7.5 +/- 0.6 micrograms/l, p less than 0.001) and their response to TRH (200 micrograms iv) was impaired (mean delta % at peak, 45.4 +/- 9.5 vs + 641 +/- 47.5, p less than 0.001). After kidney transplantation a dramatic decrease in serum PRL concentrations was observed in all patients, followed by a slight upward trend in the following two weeks, while TRH test administered on 3rd, 7th and 14th day, induced a progressive increase in serum PRL responses (delta % at peak, 201 +/- 43.3, 220 +/- 37.1 and 305 +/- 15.5, respectively). No difference in serum PRL patterns was observed between patients with (8 cases) and without (17 cases) clinical features and kidney fine needle biopsies suggestive of rejection. Basal serum Zn levels of patients with CRF (18.1 +/- 0.6 mumol/l) were similar to those observed in normals (17.7 +/- 0.2 mumol/l) and without any correlation with serum PRL levels. A decrement in serum Zn was recorded during CsA infusion and on the first day after the surgery, followed by a slight and slow upward trend. Basal serum thymulin titers were low [2.92 +/- 0.18 (1/log2)], were further reduced after CsA infusion [1.68 +/- 0.15 (1/log2)] and returned to the pretransplant levels in the two weeks after grafting.(ABSTRACT TRUNCATED AT 250 WORDS)
对25例接受肾移植并用环孢素A(CsA)进行免疫抑制的慢性肾衰竭(CRF)患者,研究了催乳素(PRL)、胸腺素和锌之间的相互关系。还研究了血清PRL水平在预测同种异体移植排斥反应中的可能作用。肾移植前,患者血清PRL水平显著高于正常人(均值±标准误,28.3±7.1对7.5±0.6微克/升,p<0.001),且其对促甲状腺激素释放激素(TRH,静脉注射200微克)的反应受损(峰值时平均变化百分比,45.4±9.5对+641±47.5,p<0.001)。肾移植后,所有患者血清PRL浓度均显著下降,随后两周略有上升趋势,而在第3天、第7天和第14天进行TRH试验时,血清PRL反应逐渐增加(峰值时变化百分比分别为201±43.3、220±37.1和305±15.5)。有临床特征及肾细针活检提示排斥反应的患者(8例)与无此表现的患者(17例)之间,血清PRL模式无差异。CRF患者的基础血清锌水平(18.1±0.6微摩尔/升)与正常人(17.7±0.2微摩尔/升)相似,且与血清PRL水平无任何相关性。在输注CsA期间及术后第一天,血清锌水平下降,随后呈轻微缓慢上升趋势。基础血清胸腺素滴度较低[2.92±0.18(1/log2)],输注CsA后进一步降低[1.68±0.15(1/log2)],移植后两周恢复至移植前水平。(摘要截断于250字)